Call Now Open

Oxford-Harrington Rare Disease Scholar Award

You've just added:

Home / News

News + Media

January 08, 2016

Harrington Distinguished Scholar Announces Company Collaboration with Bristol-Myers Squibb

Cleveland– January 8, 2016 – Dual Therapeutics, LLC (“Dual Therapeutics”) today announced a strategic collaboration with Bristol-Myers Squibb (NYSE: BMY) to advance small molecule compounds for the treatment of cancer and other diseases. Dual Therapeutics’ small-molecule modulators simultaneously block multiple cancer... Continue Reading

May 01, 2015

A Drug that Regenerates Pancreas Cells to Treat Diabetes

- 2015 Harrington Scholar-Innovator Continue Reading

January 01, 2015

2015-2016 Harrington Annual Publication

Momentum: Moving Medicine Forward Continue Reading

January 01, 2014

2014-2015 Harrington Annual Publication

Exploring New Directions Continue Reading

January 01, 2013

2013-2014 Harrington Annual Publication

Creating Connections Continue Reading

January 01, 2012

2012-2013 Harrington Annual Publication

Celebrating a Year of Accomplishments Continue Reading